> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-158/
- Published: 2017-11-26T12:00:00.000Z
- Updated: 2026-09-14T23:03:16.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140207

[**Guide on Generic Abuse-deterrent Opioids**](https://www.fdaweb.com/guide-on-generic-abuse-deterrent-opioids/)  
*Federal Register* notice: FDA makes available a guidance entitled “General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products.” 11/22/2017

[**Panel to Review Clarus Therapeutics Testosterone Replacement**](https://www.fdaweb.com/panel-to-review-clarus-therapeutics-testosterone-replacement/)  
*Federal Register* notice: FDA announces a 1/9/2018 Bone, Reproductive and Urologic Drugs Advisory Committee meeting in Hyattsville, MD that will review testosterone replacement NDA. 11/22/2017

[**10th Annual Sentinel Public Workshop**](https://www.fdaweb.com/10th-annual-sentinel-public-workshop/)  
*Federal Register* notice: FDA announces a 2/7-8/2018 public workshop entitled “Tenth Annual Sentinel Initiative Public Workshop.” 11/22/2017

[**Comments Sought on Info Collection Under 513(g) Devices**](https://www.fdaweb.com/comments-sought-on-info-collection-under-513-g-devices/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “513(g) Request for Information OMB Control Number 0910-0705.” 11/21/2017

[**Comments Sought on Device Accredited Person Inspections**](https://www.fdaweb.com/comments-sought-on-device-accredited-person-inspections/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for its guidance on “Notification of the Intent To Use an Accredited Person Under the Accredited Persons Inspection Program OMB Control Number 0910-0569.” 11/21/2017

[**Comments Extended on Cardiac Troponin Assays**](https://www.fdaweb.com/comments-extended-on-cardiac-troponin-assays/)  
*Federal Register* notice: FDA extends its comment period provided in a 7/31 Federal Register notice entitled “Cardiac Troponin Assays; Public Workshop; Request for Comments.” 11/20/2017

[**Comments Sought on Petition for OTC Denture Repair Kits**](https://www.fdaweb.com/comments-sought-on-petition-for-otc-denture-repair-kits/)  
*Federal Register* notice: FDA seeks comments on a petition from an undisclosed applicant requesting exemption from premarket notification requirements for over-the-counter denture repair kits. 11/20/2017

[**Guide on Same Procedure Exception for Tissue Products**](https://www.fdaweb.com/guide-on-same-procedure-exception-for-tissue-products/) *Federal Register* notice: FDA makes available a guidance on “Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception.” 11/20/2017